$ALMR News
Last published 1w ago
- 1w agoALMRAlamar Biosciences to Participate in Upcoming Investor ConferencesGlobeNewswireFremont, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (NASDAQ:ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of disease, today announced the company will be
- 1w agoALMRAlamar Biosciences, Inc. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 5.02 Item 9.01
- 1w agoALMRAlamar Biosciences Reports Third Quarter 2026 Financial Results and Raises 2026 Revenue GuidanceGlobeNewswireFREMONT, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (NASDAQ:ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of disease, today reported financial results for
- 1w agoALMRGSKAlamar Biosciences Partners with GSK on Large-Scale Proteomic Study to Advance Precision MedicineGlobeNewswireFREMONT, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (NASDAQ:ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of disease, today announced a strategic
- 1w agoALMRNHLTYUPDATE -- Alamar Biosciences and Nightingale Health to Lead UK Biobank 80,000-Sample Neurodegenerative Disease StudyGlobeNewswireFREMONT, Calif. and HELSINKI, Finland, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (NASDAQ:ALMR) and Nightingale Health Plc (Nasdaq Helsinki: HEALTH, OTCQX:NHLTY, NGHLF) today announced the launch of
- 1w agoALMRNHLTYAlamar Biosciences and Nightingale Health to Lead UK Biobank 80,000-Sample Neurodegenerative Disease StudyGlobeNewswireFREMONT, Calif. and HELSINKI, Finland, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (NASDAQ:ALMR) and Nightingale Health Plc (Nasdaq Helsinki: HEALTH, OTCQX:NHLTY, NGHLF) today announced the launch of
- 2w agoALMREmory Researchers Identify Blood Protein Signature That Detects ALS With 98% Accuracy Using Alamar TechnologyGlobeNewswireFremont, Calif., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (NASDAQ:ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of disease, today announced researchers at Emory
- 1mo agoALMRAlamar Biosciences to Report Third Quarter 2026 Financial Results on November 3, 2026GlobeNewswireFREMONT, Calif., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (NASDAQ:ALMR), a leader in Precision Proteomics dedicated to enabling the earliest detection of disease, today announced it will report
- 2mo agoALMRAlamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare ConferenceGlobeNewswireFREMONT, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (NASDAQ:ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of disease, today announced the company will be
- 3mo agoALMRAlamar Biosciences Reports Second Quarter 2026 Financial Results and Provides 2026 Revenue GuidanceGlobeNewswireFREMONT, Calif., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (NASDAQ:ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of disease, today reported financial results for
- 3mo agoALMRAlamar Biosciences Expands Global Partnership with Alzheimer’s Disease Data Initiative and Gates VenturesGlobeNewswireExpanded collaboration applies multiplex protein profiling across 86,000 additional samples, enabling researchers to move beyond single biomarkers toward a precision-medicine understanding of disease heterogeneity,
- 3mo agoALMRAlamar Biosciences Launches NULISAseq™ Immune 340 Panel for Comprehensive Profiling of the Immune ProteomeGlobeNewswireFremont, CA, July 28, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (NASDAQ:ALMR), a leader in precision proteomics dedicated to advancing the early detection of disease, today announced the launch of the
- 4mo agoALMRAlamar Biosciences to Report Second Quarter 2026 Financial Results on August 10, 2026GlobeNewswireFREMONT, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (NASDAQ:ALMR), a leader in Precision Proteomics dedicated to enabling the earliest detection of disease, today announced it will report
- 4mo agoALMRAlamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative DiseasesGlobeNewswireFremont, CA, July 13, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (NASDAQ:ALMR), a leader in precision proteomics dedicated to advancing the early detection of disease, today announced a partnership with leading
- 4mo agoALMRAlamar Biosciences Launches the First Multiplexed Blood-based Immunoassay for eMTBR-Tau, One of the Most Important Biomarkers in Alzheimer’s Disease ResearchGlobeNewswireFremont, CA, July 07, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (NASDAQ:ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of disease, today launched the first commercial
- 5mo agoALMRAlamar Biosciences Makes Home-Collected Fingerstick Samples Compatible with Ultra High-Sensitivity, Multiplex ProteomicsGlobeNewswireFremont, CA, June 02, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (NASDAQ:ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of disease, today launched the NULISA™ Dried
- 6mo agoALMRAlamar Biosciences Reports First Quarter 2026 Financial ResultsGlobeNewswireFREMONT, Calif., May 08, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (NASDAQ:ALMR), a leader in Precision Proteomics dedicated to enabling the earliest detection of disease, today reported financial results for
- 6mo agoALMRAlamar Biosciences to Participate in BofA Securities 2026 Healthcare ConferenceGlobeNewswireFREMONT, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (NASDAQ:ALMR), a leader in Precision Proteomics dedicated to enabling the earliest detection of disease, today announced it will be
- 6mo agoALMRAlamar Biosciences to Report First Quarter 2026 Financial Results on May 8, 2026GlobeNewswireFREMONT, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (NASDAQ:ALMR), a leader in Precision Proteomics dedicated to enabling the earliest detection of disease, today announced it will publish its
- 6mo agoALMRPrecision Proteomics Leader Alamar Biosciences Lists on NASDAQPR NewswireAlamar Biosciences, a portfolio company of Qiming Venture Partners and a global leader in precision proteomics, successfully listed on the NASDAQ...
- 6mo agoALMRPrecision Proteomics Leader Alamar Biosciences Lists on NASDAQPR NewswireAlamar Biosciences, a portfolio company of Qiming Venture Partners and a global leader in precision proteomics, successfully listed on the NASDAQ...